Triphala is often introduced as a bowel-regulating powder, but modern investigations have also examined it in oral care, metabolic markers, oxidative stress, the gut microbiome, nervous-system models, skin repair, eye-lens models, and cancer biology. The evidence is uneven: oral-health research includes several human trials, while many other proposed benefits remain preclinical and should not be presented as established treatments.

Official Triphala Churna contains equal parts of the dried fruit pericarps of Haritaki (Terminalia chebula Retz.), Bibhitaki or Vibhitaka (Terminalia bellirica (Gaertn.) Roxb.), and Amalaki (Phyllanthus emblica L.; older literature also uses Emblica officinalis). The Sanskrit name means “three fruits.” Charaka Samhita, Chikitsa Sthana 1.3, records Triphala Rasayana preparations, confirming a classical role broader than occasional laxative use. Our complete Triphala guide covers its digestive context.

The Constituents Behind Triphala’s Wider Activity

Analytical studies identify tannins and related polyphenols in Triphala and its fruits, including gallic acid, ellagic acid, chebulagic acid, chebulinic acid, and corilagin. Amalaki also supplies ascorbic acid, although the amount in a finished product varies with raw material, processing, storage, and assay method. These constituents can show antioxidant, antimicrobial, enzyme-modulating, and cell-signalling effects in laboratory systems; chemistry alone does not establish a clinical benefit.

A churna, aqueous extract, hydroalcoholic extract, tablet, mouth rinse, ointment, and medicated ghee are not interchangeable. Extraction changes the concentration and proportion of constituents, and commercial products vary in botanical identity and marker content. Findings from one preparation therefore cannot supply a universal dose or indication.

Benefit 1: Neuroprotective and Cognitive Potential

Triphala has shown neuroprotective activity in cell, zebrafish, and rodent models. A 2024 sleep-deprivation study reported improved cognitive and anxiety-like outcomes in animals alongside activation of the Nrf2/HO-1 antioxidant pathway. This supports further investigation, not a claim that Triphala treats dementia, depression, anxiety, or memory loss in people. Charaka’s Triphala Rasayana passages include traditional claims concerning medha, memory, strength, and longevity within specific regimens rather than a generic capsule protocol.

Benefit 2: Plaque and Gingival Control

Oral health has the strongest direct clinical evidence among these benefits. Randomized trials comparing standardized Triphala rinses with chlorhexidine reported reductions in plaque and gingival indices over short periods. A 2024 systematic review in children found no significant difference between the two groups for plaque or gingivitis reduction, although only a small number of variable trials were available. Triphala rinse remains an adjunct to brushing, interdental cleaning, and professional dental care, not a treatment for caries, abscess, or advanced periodontitis.

Benefit 3: Ocular Antioxidant Research

Triphala’s eye-related evidence is experimental. In a selenite-induced cataract model, Triphala extract helped preserve reduced glutathione and antioxidant-enzyme activity and reduced cataract formation in isolated lenses and rat pups; another rat study examined diabetic retinopathy. These models do not establish prevention or treatment of human eye disease. Homemade Triphala water should not be placed in the eyes because it is not sterile; cataract, visual loss, pain, redness, flashes, or floaters require professional examination.

Benefit 4: Anticancer Activity in Preclinical Models

Triphala extracts have inhibited proliferation or promoted cell death in laboratory models involving breast, colon, pancreatic, and other cancer cells, with proposed effects on apoptosis and several signalling pathways. Some animal tumor models have also been studied. This remains preclinical pharmacology. Triphala is not an established cancer treatment, and laboratory “selectivity” does not predict safety or efficacy in patients. Anyone receiving chemotherapy, radiotherapy, immunotherapy, hormonal therapy, or surgery should discuss its use with the oncology team.

Benefit 5: Glucose and Metabolic Markers

A 2021 systematic review of human studies reported lower fasting glucose and HbA1c in Triphala-treated participants with diabetes, while effects were not significant in people without diabetes. The authors also noted small samples, heterogeneous products, and the need for stronger trials. Laboratory inhibition of carbohydrate-digesting enzymes is a possible mechanism, but claims that chromium or one isolated acid explains the whole effect are not established. Triphala should not replace diabetes treatment, and glucose should be monitored when any supplement is added. See our Ayurvedic diabetes management guide.

Benefit 6: Interaction with the Gut Microbiome

Intestinal microorganisms can metabolize Triphala polyphenols, and ellagic-acid derivatives may be converted into urolithins in people capable of producing them. In vitro fermentation studies have reported microbial and metabolic changes, while a small double-blind human pilot evaluated Triphala’s effect on gut microbiota. This supports a plausible interaction but not the claim that Triphala reliably increases selected “good bacteria,” removes an entire bacterial phylum, or permanently resets every user’s microbiome. Diet, baseline microbiota, extract composition, and urolithin-producing capacity affect the response.

Benefit 7: Skin Protection and Wound-Healing Research

Topical Triphala has been studied mainly in cells and animals. In one rat study, Triphala ointment improved healing measures in full-thickness wounds infected with Pseudomonas aeruginosa; a Triphala-containing collagen sponge was also evaluated in an animal model. Separate cell work examined dermal fibroblasts and keratinocytes. These findings do not establish home treatment for ulcers, burns, surgical wounds, diabetic foot wounds, or infected skin. Non-sterile powders or ghee should not be applied to an open wound.

Benefit 8: Lipid and Cardiometabolic Markers

The 2021 systematic review found reductions in total cholesterol, LDL cholesterol, and triglycerides in several Triphala studies, but products, populations, doses, and durations differed. A separate placebo-controlled trial of Guggulu plus Triphala found no advantage over placebo for total or LDL cholesterol, body mass index, or waist circumference after three months. Triphala is therefore not a botanical statin, and a confirmed human HMG-CoA reductase mechanism should not be claimed. It cannot replace lipid-lowering medicine, diet, exercise, or cardiovascular evaluation. Our Arjuna heart-health guide provides complementary context.

Comprehensive Evidence Summary

The table separates human findings from laboratory and animal results so that promising mechanisms are not mistaken for proven treatment.

Area Best verified evidence Responsible interpretation
Neuroprotection Cell, zebrafish, and rodent studies No established human cognitive indication
Oral health Short randomized trials and reviews May support plaque and gingivitis control as an adjunct
Eye health Lens and animal models No human proof; never use homemade eye drops
Cancer biology Cell and animal studies Preclinical only; never replace oncology care
Glucose control Small heterogeneous human studies Possible benefit in diabetes; confirmation needed
Microbiome In vitro work and a small human pilot Interaction is plausible but highly individual
Skin and wounds Cell and animal wound models Not established for routine human wound care
Lipids Mixed small trials and a systematic review Possible adjunct; not a statin equivalent

What the Human Studies Actually Tested

Research doses describe specific products, not universal prescriptions. A preliminary 2025 post-COVID trial used 1,000 mg/day, five days per week for eight weeks; biomarkers improved within the Triphala group, but none of the primary outcomes differed significantly from placebo. A phase I study gave 2,500 mg/day of a defined aqueous extract to 20 healthy adults for four weeks and reported no serious adverse effects. Oral-health trials used rinse concentrations from approximately 0.4% to 6%. These different products and endpoints cannot establish one “best dose” for cognition, diabetes, cholesterol, inflammation, or longevity.

Classical use likewise depends on preparation, timing, vehicle, digestive strength, constitution, and purpose. Powder, decoction, rasayana, ghrita, and compound formulations are distinct. A qualified Ayurvedic practitioner should decide whether Triphala is appropriate and which form is suitable when the goal is treatment rather than occasional digestive support.

Combining Triphala with Other Ayurvedic Medicines

Combining Triphala with Brahmi, Ashwagandha, Shatavari, Arjuna, or Guggulu is not automatically synergistic; each addition changes indications, tolerability, and interaction risk. Triphala Guggulu is an official compound formulation listed in the Ayurvedic Pharmacopoeia/Formulary framework and is not equivalent to casually mixing two supplements. Selection should follow an Ayurvedic assessment and review of conventional medicines. See our Guggulu evidence guide.

Safety and Disclaimer: This article is educational and is not medical advice. Triphala may cause loose stools, abdominal discomfort, or intolerance, and long-term safety data for many products are limited. People who are pregnant or breastfeeding, children, those with significant gastrointestinal, liver, kidney, bleeding, or metabolic disorders, and anyone taking prescription medicines should consult a qualified Ayurvedic practitioner and healthcare provider before use. Do not replace prescribed treatment, and disclose supplements before surgery or cancer therapy. Choose a product with botanical identity and contaminant testing; heavy-metal contamination has been documented in some Ayurvedic products as a category.

Actionable Tip: Check that the label names all three botanicals and plant parts, states the powder amount or extract ratio, and provides batch, expiry, and credible testing information. For oral care, use a standardized rinse intended for that purpose and continue brushing, interdental cleaning, and dental review. Do not convert culinary powder into eye drops, wound dressings, or treatment for cancer, diabetes, or cardiovascular disease.

References

  1. Archive (archive.org)
  2. Charaka Samhita — Smruti %28memory%29
  3. Therapeutic Uses of Triphala in Ayurvedic Medicine (2017), PubMed Central
  4. Triphala ameliorates cognitive deficits and anxiety via activation of the Nrf2/HO-1 axis in chronic sleep-deprived mice (2024), PubMed
  5. A randomized clinical trial to evaluate and compare the efficacy of triphala mouthwash with 0.2% chlorhexidine in hospitalized patients with periodontal diseases (2014), PubMed
  6. Comparative anti-plaque and anti-gingivitis efficiency of Triphala versus chlorhexidine mouthwashes in children: a systematic review and meta-analysis (2024), PubMed
  7. Evaluation of anticataract potential of Triphala in selenite-induced cataract: In vitro and in vivo studies (2010), PubMed
  8. Triphala churna ameliorates retinopathy in diabetic rats (2022), PubMed
  9. Mskcc (mskcc.org)
  10. Effects of Triphala on Lipid and Glucose Profiles and Anthropometric Parameters: A Systematic Review (2021), PubMed
  11. Modulatory Effects of Triphala and Manjistha Dietary Supplementation on Human Gut Microbiota: A Double-Blind, Randomized, Placebo-Controlled Pilot Study (2020), PubMed
  12. Triphala promotes healing of infected full-thickness dermal wound (2008), PubMed
  13. Protective Effects of Triphala on Dermal Fibroblasts and Human Keratinocytes (2016), PubMed
  14. Guggulu and Triphala for the Treatment of Hypercholesterolaemia: A Placebo-Controlled, Double-Blind, Randomised Trial (2021), PubMed
  15. SAGE Journals
  16. Study of the safety of oral Triphala aqueous extract on healthy volunteers (2020), PubMed
  17. Ayurvedic Pharmacopoeia of India
  18. NCCIH